Breast Cancer Monitoring

HALO is a microscopic cellular test for breast cancer risk. This 5 minute test determines whether or not there are abnormal cells in the breast ducts. HALO is recommended for women age 25 and older as part of their annual exam. This new method of breast cancer risk monitoring adds an extra layer of safety to every woman's life. Learn more at www.neomatrix.com ... halo microscopic cellular test breast cancer monitoring risk ducts annual exam abnormal cells determination neomatrix woman's ...

» View the original video «

YouTube | November 24, 2008

Tags:. .abnormal. .microscopic. .cellular. .exam. .ducts